Literature DB >> 9639690

Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation.

O Hyeon Joo1, M P Hande, P M Lansdorp, A T Natarajan.   

Abstract

Telomerase, a ribonucleoprotein enzyme, has been detected in immortalised cells and in majority of human cancers. Numerical and structural chromosome aberrations are commonly observed in tumour cell lines. To study the expression of telomerase and its influence on the formation of chromosomal aberrations, human colon carcinoma cell line (SW480) and human nonpolyposis colorectal carcinoma (HNPCC) cell lines (NA50600, NA59 and NA61) were exposed to 2 or 4 Gy X-rays. Increased telomerase activity was observed in all these cell lines at 24 h postirradiation and a 3 to 7 fold increase was seen at 4 Gy dose as detected by Telomere Repeat Amplification Protocol. Chromosomal rearrangements (dicentrics, translocations and breaks/fragments) analysed by Giemsa staining and chromosome painting were increased significantly following X- Quantitative fluorescence in situ hybridisation using a peptide nucleic acid telomeric probe to measure telomere length at irradiation chromosomal level revealed that all cell lines have very short telomeres in the range of 0.29 to 2.1 kb. Following X-irradiation, an increase in the chromosome end-to-end (telomere) associations was observed. The present results demonstrate that presence or upregulation of telomerase activity did not prevent the formation of chromosome aberrations and/or telomere associations in tumour cell lines after X-irradiation. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639690     DOI: 10.1016/s0027-5107(97)00321-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide.

Authors:  T J Moriarty; S Dupuis; C Autexier
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

2.  Changes in telomere length distribution in low-dose X-ray-irradiated human umbilical vein endothelial cells.

Authors:  Jing-Zhi Guan; Wei Ping Guan; Toyoki Maeda; Naoki Makino
Journal:  Mol Cell Biochem       Date:  2014-07-25       Impact factor: 3.396

3.  Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis.

Authors:  Dao-Yong Liu; Zhi-Hai Peng; Guo-Qiang Qiu; Chong-Zhi Zhou
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

4.  Irradiation-induced telomerase activity and gastric cancer risk: a case-control analysis in a Chinese Han population.

Authors:  Xianli He; Qing Qiao; Naijian Ge; Jing Nan; Shuqun Shen; Zizhong Wang; Yefa Yang; Guoqiang Bao
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

5.  Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells.

Authors:  T Yajima; A Yagihashi; H Kameshima; D Kobayashi; K Hirata; N Watanabe
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

6.  Telomere profiling: toward glioblastoma personalized medicine.

Authors:  Sylvain Ferrandon; Paul Saultier; Julien Carras; Priscillia Battiston-Montagne; Gersende Alphonse; Michael Beuve; Céline Malleval; Jérôme Honnorat; Tania Slatter; Noelyn Hung; Janice Royds; Claire Rodriguez-Lafrasse; Delphine Poncet
Journal:  Mol Neurobiol       Date:  2012-10-12       Impact factor: 5.682

7.  Telomeres and Telomerase in the Radiation Response: Implications for Instability, Reprograming, and Carcinogenesis.

Authors:  Brock J Sishc; Christopher B Nelson; Miles J McKenna; Christine L R Battaglia; Andrea Herndon; Rupa Idate; Howard L Liber; Susan M Bailey
Journal:  Front Oncol       Date:  2015-11-24       Impact factor: 6.244

8.  Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines.

Authors:  P Millet; C Granotier; O Etienne; F D Boussin
Journal:  Int J Oncol       Date:  2013-05-31       Impact factor: 5.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.